Opus Genetics, Inc. (IRD)
4.605
+0.16
(+3.48%)
USD |
NASDAQ |
Sep 03, 16:00
4.65
+0.04
(+0.98%)
After-Hours: 18:24
Opus Genetics Total Liabilities (Quarterly) : 105.95M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 105.95M |
| March 31, 2026 | 112.62M |
| December 31, 2025 | 34.92M |
| September 30, 2025 | 30.16M |
| June 30, 2025 | 21.19M |
| March 31, 2025 | 43.09M |
| December 31, 2024 | 30.16M |
| September 30, 2024 | 6.089M |
| June 30, 2024 | 4.198M |
| March 31, 2024 | 5.787M |
| December 31, 2023 | 4.042M |
| September 30, 2023 | 3.909M |
| June 30, 2023 | 5.761M |
| March 31, 2023 | 4.154M |
| December 31, 2022 | 2.753M |
| September 30, 2022 | 2.691M |
| June 30, 2022 | 3.304M |
| March 31, 2022 | 3.213M |
| December 31, 2021 | 3.855M |
| September 30, 2021 | 2.638M |
| June 30, 2021 | 2.699M |
| March 31, 2021 | 2.31M |
| December 31, 2020 | |
| September 30, 2020 | 3.120M |
| June 30, 2020 | 3.246M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.108M |
| December 31, 2019 | 3.011M |
| September 30, 2019 | 3.226M |
| June 30, 2019 | 4.054M |
| March 31, 2019 | 3.485M |
| December 31, 2018 | 5.48M |
| September 30, 2018 | 7.463M |
| June 30, 2018 | 6.813M |
| March 31, 2018 | 7.584M |
| December 31, 2017 | 11.52M |
| September 30, 2017 | 9.470M |
| June 30, 2017 | 12.19M |
| March 31, 2017 | 18.45M |
| December 31, 2016 | 3.985M |
| September 30, 2016 | 5.502M |
| June 30, 2016 | 4.716M |
| March 31, 2016 | 8.348M |
| December 31, 2015 | 6.030M |
| September 30, 2015 | 5.368M |
| June 30, 2015 | 5.941M |
| March 31, 2015 | 7.104M |
| December 31, 2014 | 6.953M |
| September 30, 2014 | 7.856M |
| June 30, 2014 | 8.936M |
| March 31, 2014 | 13.09M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 68.16M |
| Praxis Precision Medicines, Inc. | 49.06M |
| Faeth Therapeutics, Inc. | 9.581M |
| Jade Biosciences, Inc. | 32.20M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 92.97M |
| Shareholders Equity (Quarterly) | -12.99M |
| Debt to Equity Ratio | -2.788 |
| Current Ratio | 12.19 |
| Net Debt Paydown Yield | -1.02% |